{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T09:56:02Z","timestamp":1772272562526,"version":"3.50.1"},"reference-count":34,"publisher":"King Faisal Specialist Hospital and Research Centre","issue":"4","funder":[{"name":"Dr. Nasser Al-Rasheed, Research Chair in Ophthalmology"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Saudi Medicine"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.5144\/0256-4947.2014.328","type":"journal-article","created":{"date-parts":[[2017,3,24]],"date-time":"2017-03-24T17:38:25Z","timestamp":1490377105000},"page":"328-333","source":"Crossref","is-referenced-by-count":12,"title":["Cataract surgery under systemic infliximab therapy in patients with refractory uveitis associated with Behcet disease"],"prefix":"10.5144","volume":"34","author":[{"given":"Abullah","family":"Alfawaz","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, College of Medicine, King Abdulaziz University Hospital, Riyadh, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sultan","family":"Alrashidi","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Qassim University, Al Qassim, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hatem","family":"Kalantan","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, College of Medicine, King Abdulaziz University Hospital, Riyadh, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hani","family":"Al-Mezaine","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, College of Medicine, King Abdulaziz University Hospital, Riyadh, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed M.","family":"Abu El-Asrar","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, College of Medicine, King Abdulaziz University Hospital, Riyadh, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3134","reference":[{"issue":"8697","key":"e_1_3_2_2_2","first-page":"1078","article-title":"Criteria for diagnosis of Beh\u00e7et\u2019s disease","volume":"335","author":"International Study Group for Beh\u00e7et\u2019s Disease","year":"1990","journal-title":"Lancet"},{"key":"e_1_3_2_3_2","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1517\/13543784.9.9.1993","article-title":"New approaches to Beh\u00e7et\u2019s disease","volume":"9","author":"Sakane T","year":"2000","journal-title":"Expert Opin Investig Drugs"},{"key":"e_1_3_2_4_2","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.ajo.2004.03.022","article-title":"Uveitis in Beh\u00e7et\u2019s disease: an analysis of 880 patients","volume":"138","author":"Tugal-Tutkun I","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"e_1_3_2_5_2","first-page":"1544","article-title":"Overproduction of monocyte derived tumor necrosis factor alpha, interleukin (IL) 6, IL-8 and increased neutrophil superoxide generation in Beh\u00e7et\u2019s disease: a comparative study with familial Mediterranean fever and healthy subjects","volume":"20","author":"Mage JL","year":"1993","journal-title":"J Rheumatol"},{"key":"e_1_3_2_6_2","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.cyto.2003.09.003","article-title":"Cytokine production profile in patients with Beh\u00e7et\u2019s disease treated with infliximab","volume":"24","author":"Misumi M","year":"2003","journal-title":"Cytokine"},{"key":"e_1_3_2_7_2","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1080\/09629350220131935","article-title":"Serum levels of TNF-alpha, sIL-2R, IL-6, and IL-8 are increased and associated with elevated lipid peroxidation in patients with Beh\u00e7et\u2019s disease","volume":"11","author":"Evereklioglu C","year":"2002","journal-title":"Mediators Inflamm"},{"key":"e_1_3_2_8_2","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1076\/ocii.12.1.53.28062","article-title":"The demonstration of serum interleukin 6\u20138, tumor necrosis factor-alpha, complement, and immunoglobulin levels in Beh\u00e7et\u2019s disease with ocular involvement","volume":"12","author":"Bardak Y","year":"2004","journal-title":"Ocul Immunol Inflamm"},{"key":"e_1_3_2_9_2","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.clim.2011.01.014","article-title":"Cytokine profiles in aqueous humor of patients with different clinical entities of endogenous uveitis","volume":"139","author":"El-Asrar AM","year":"2011","journal-title":"Clin Immunol"},{"key":"e_1_3_2_10_2","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.imbio.2011.03.007","article-title":"CXC chemokine expression profiles in aqueous humor of patients with different clinical entities of endogenous uveitis","volume":"216","author":"El-Asrar AM","year":"2011","journal-title":"Immunobiology"},{"key":"e_1_3_2_11_2","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1093\/rheumatology\/kem101","article-title":"Long-term efficacy of infliximab in refractory posterior uveitis of Beh\u00e7et\u2019s disease: a 24-month follow-up study","volume":"46","author":"Niccoli L","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"e_1_3_2_12_2","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s10384-006-0425-y","article-title":"Infliximab treatment for ocular and extraocular manifestations of Beh\u00e7et\u2019s disease","volume":"51","author":"Accorinti M","year":"2007","journal-title":"Jpn J Ophthalmol"},{"key":"e_1_3_2_13_2","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1136\/bjo.2010.194464","article-title":"Decreased ocular inflammatory attacks and background retinal and disc vascular leakage in patients with Beh\u00e7et\u2019s disease on infliximab therapy","volume":"95","author":"Keino H","year":"2011","journal-title":"Br J Ophthalmol"},{"key":"e_1_3_2_14_2","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.ajo.2008.09.010","article-title":"Infliximab effects compared to conventional therapy in the management of retinal vasculitis in Beh\u00e7et\u2019s disease","volume":"146","author":"Tabbara KF","year":"2008","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"e_1_3_2_15_2","doi-asserted-by":"crossref","first-page":"198","DOI":"10.3109\/09273948.2012.670360","article-title":"Long-term efficacy and safety of infliximab in the treatment of Beh\u00e7et\u2019s disease","volume":"20","author":"Capella MJ","year":"2012","journal-title":"Ocul Immunol Inflamm"},{"key":"e_1_3_2_16_2","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1001\/archophthalmol.2011.2698","article-title":"Multicenter study of infliximab for refractory uveoretinitis in Beh\u00e7et\u2019s disease","volume":"130","author":"Okada AA","year":"2012","journal-title":"Arch Ophthalmol"},{"key":"e_1_3_2_17_2","doi-asserted-by":"crossref","first-page":"468","DOI":"10.3109\/09273948.2013.779727","article-title":"Long-term clinical outcomes in patients with refractory uveitis associated with Beh\u00e7et\u2019s disease treated with infliximab","volume":"21","author":"Al Rashidi S","year":"2013","journal-title":"Ocul Immunol Inflamm"},{"key":"e_1_3_2_18_2","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1167\/iovs.10-5916","article-title":"Induction of regulatory T cells by infliximab in Beh\u00e7et\u2019s disease","volume":"52","author":"Sugita S","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_3_2_19_2","doi-asserted-by":"crossref","first-page":"424","DOI":"10.3109\/09273948.2010.502284","article-title":"Patterns of uveitis in patients admitted to a University Hospital in Riyadh, Saudi Arabia","volume":"18","author":"Al-Mezaine HS","year":"2010","journal-title":"Ocul Immunol Inflamm"},{"issue":"1","key":"e_1_3_2_20_2","first-page":"20","article-title":"Prognosis in Beh\u00e7et\u2019s disease","volume":"17","author":"Pivetti Pezzi P","year":"1985","journal-title":"Ann Ophthalmol"},{"issue":"4","key":"e_1_3_2_21_2","first-page":"148","article-title":"Long term effects of cyclophosphamide and colchicine treatment in Beh\u00e7et\u2019s disease","volume":"23","author":"Kazokoglu H","year":"1991","journal-title":"Ann Ophthalmol"},{"key":"e_1_3_2_22_2","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.ophtha.2007.04.056","article-title":"Clinical features of chinese patients with Beh\u00e7et\u2019s disease","volume":"115","author":"Yang P","year":"2008","journal-title":"Ophthalmology"},{"key":"e_1_3_2_23_2","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/0039-6257(90)90068-7","article-title":"Cataract extraction in uveitis patients","volume":"35","author":"Hooper PL","year":"1990","journal-title":"Surv Ophthalmol"},{"key":"e_1_3_2_24_2","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ajo.2005.03.057","article-title":"Standardization of uveitis nomenclature for reporting clinical data: results of the First International Workshop","volume":"140","author":"Jabs DA","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"e_1_3_2_25_2","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1600-0420.1996.tb00687.x","article-title":"Cataract extraction in Beh\u00e7et\u2019s disease","volume":"74","author":"Ciftci OU","year":"1996","journal-title":"Acta Ophthalmol Scand"},{"key":"e_1_3_2_26_2","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1034\/j.1600-0420.2000.078006680.x","article-title":"The results of cataract extraction and intraocular lens implantation in patients with Beh\u00e7et\u2019s disease","volume":"78","author":"S\u00fcll\u00fc Y","year":"2000","journal-title":"Acta Ophthalmol Scand"},{"key":"e_1_3_2_27_2","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S0886-3350(01)01023-9","article-title":"Cataract surgery in patients with Beh\u00e7et\u2019s disease","volume":"28","author":"Kadayifcilar S","year":"2002","journal-title":"J Cataract Refract Surg"},{"key":"e_1_3_2_28_2","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1016\/j.jcrs.2012.04.027","article-title":"Male sex, erythema nodosum, and electroretinography as predictors of visual prognosis after cataract surgery in patients with Beh\u00e7et disease","volume":"38","author":"Hu K","year":"2012","journal-title":"J Cataract Refract Surg"},{"issue":"3","key":"e_1_3_2_29_2","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3928\/1542-8877-20040501-08","article-title":"Phacoemulsification cataract extraction and intraocular lens implantation in patients with Beh\u00e7et\u2019s disease","volume":"35","author":"Berker N","year":"2004","journal-title":"Ophthalmic Surg Lasers Imaging"},{"key":"e_1_3_2_30_2","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1089\/jop.2009.0054","article-title":"Cataract surgery under infliximab therapy in a patient with Beh\u00e7et\u2019s disease","volume":"25","author":"Noda E","year":"2009","journal-title":"J Ocul Pharmacol Ther"},{"key":"e_1_3_2_31_2","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1007\/s10384-010-0824-y","article-title":"Intraocular surgery in patients receiving infliximab therapy for Beh\u00e7et\u2019s disease","volume":"54","author":"Sakai T","year":"2010","journal-title":"Jpn J Ophthalmol"},{"key":"e_1_3_2_32_2","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1159\/000329190","article-title":"Clinical course before and after cataract and glaucoma surgery under systemic infliximab therapy in patients with Beh\u00e7et\u2019s disease","volume":"2","author":"Nishida T","year":"2011","journal-title":"Case Rep Ophthalmol"},{"key":"e_1_3_2_33_2","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/art.20712","article-title":"Very early treatment with infliximab in addition to metrotrexate in early, poor-prognosis rheumatoid arthritis reduces magnetic resonance imaging evidence of synovitis and damage, with sustained benefit after infliximab withdrawal: results from a twelve-month randomized, double-blind, placebo-controlled trial","volume":"52","author":"Quinn MA","year":"2005","journal-title":"Arthritis Rheum"},{"key":"e_1_3_2_34_2","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1002\/art.22718","article-title":"Infliximab and methotrexate as induction therapy in patients with early rheumatoid arthritis","volume":"56","author":"van der Bijl AE","year":"2007","journal-title":"Arthritis Rheum"},{"key":"e_1_3_2_35_2","doi-asserted-by":"crossref","first-page":"5238","DOI":"10.3748\/wjg.v13.i39.5238","article-title":"Maintenance of remission with infliximab in inflammatory bowel disease: efficacy and safety long-term follow-up","volume":"13","author":"Caviglia R","year":"2007","journal-title":"World J Gastroenterol"}],"container-title":["Annals of Saudi Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.annsaudimed.net\/index.php\/vol34\/vol34iss4\/724.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T11:34:40Z","timestamp":1559475280000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.annsaudimed.net\/doi\/10.5144\/0256-4947.2014.328"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["10.5144\/0256-4947.2014.328"],"URL":"https:\/\/doi.org\/10.5144\/0256-4947.2014.328","relation":{},"ISSN":["0256-4947","0975-4466"],"issn-type":[{"value":"0256-4947","type":"print"},{"value":"0975-4466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7]]}}}